Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q3 FY19 results · Oct–Dec 2018
Procter & Gamble Health reported revenue from operations of ₹204.39 crore and net profit of ₹715.34 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 204.39 | — | — | 226.15 | −9.6% |
| Other income | 7.17 | — | — | 6.07 | +18.2% |
| Total income | 211.57 | — | — | 232.22 | −8.9% |
| Profit before tax | 17.89 | — | — | 59.94 | −70.2% |
| Net profit for the period | 715.34 | — | — | 52.33 | 14x |
| EPS, basic (₹) | 430.94 | — | — | 31.52 | 14x |
| Net margin (%) | 350.0 | — | 23.1 |
Standalone
- Filed with BSE
- 27 Feb 2019, 18:35 IST
- Board meeting
- 27 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Audited
- Source
- XBRL filing on BSE